Eplontersen
Oligonucleotide
Overview
Eplontersen is a oligonucleotide active pharmaceutical ingredient (ChEMBL CHEMBL4594334).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Eplontersen expires 25 Aug 2034 and exclusivity 21 Dec 2030. Generic API sourcing typically opens up once these lapse.
Verified Supplier Partner
Do you supply Eplontersen? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.